Mar 31, 2016 11:00 am UTC| Business
REHOVOT, Israel, March 31, 2016 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced financial results for the fourth...
Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies Animal Health Summit
Mar 31, 2016 11:00 am UTC| Business
OVERLAND PARK, Kan., March 31, 2016 -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health...
Mar 31, 2016 11:00 am UTC| Business
- Consistent efficacy across potential Phase 3 clinical trial endpoints - - Once-yearly or less frequent maintenance dosing expected - - Company to host conference call at9 a.m. ET today - CAMBRIDGE, Mass., March 31,...
QC Holdings, Inc. Reports 2015 Results
Mar 31, 2016 11:00 am UTC| Business
OVERLAND PARK, Kan., March 31, 2016 -- QC Holdings, Inc. (OTC PINK:QCCO) reported a loss from continuing operations of $1.0 million and revenues of $135.5 million for the year ended December 31, 2015. The year ended...
ZIOPHARM to Present at the Jefferies 2nd Annual Immuno-Oncology Summit
Mar 31, 2016 11:00 am UTC| Business
BOSTON, March 31, 2016 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the Jefferies 2nd Annual Immuno-Oncology Summit on Thursday,...
Mar 31, 2016 11:00 am UTC| Business
REDWOOD SHORES, Calif., March 31, 2016 -- Imperva, Inc. (NYSE:IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, today unveiled the March Hacker Intelligence Initiative...
Imperva Announces General Availability of Imperva CounterBreach
Mar 31, 2016 11:00 am UTC| Business
REDWOOD SHORES, Calif., March 31, 2016 -- Imperva, Inc. (NYSE:IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, today announced the general availability of Imperva...